Rice Hall James & Associates LLC bought a new stake in Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 71,363 shares of the medical instruments supplier's stock, valued at approximately $4,923,000. Rice Hall James & Associates LLC owned approximately 2.24% of Utah Medical Products as of its most recent SEC filing.
Other institutional investors and hedge funds also recently modified their holdings of the company. Ritholtz Wealth Management grew its stake in Utah Medical Products by 168.5% in the 1st quarter. Ritholtz Wealth Management now owns 14,807 shares of the medical instruments supplier's stock valued at $918,000 after purchasing an additional 9,293 shares during the period. Segall Bryant & Hamill LLC increased its position in shares of Utah Medical Products by 87.7% during the 1st quarter. Segall Bryant & Hamill LLC now owns 21,547 shares of the medical instruments supplier's stock valued at $1,336,000 after purchasing an additional 10,065 shares during the last quarter. Brandes Investment Partners LP raised its stake in shares of Utah Medical Products by 4.0% during the 4th quarter. Brandes Investment Partners LP now owns 351,322 shares of the medical instruments supplier's stock worth $19,660,000 after purchasing an additional 13,392 shares during the period. Empowered Funds LLC bought a new stake in shares of Utah Medical Products during the 1st quarter worth $203,000. Finally, Quantinno Capital Management LP boosted its holdings in shares of Utah Medical Products by 25.9% in the 1st quarter. Quantinno Capital Management LP now owns 29,841 shares of the medical instruments supplier's stock worth $1,850,000 after buying an additional 6,146 shares during the last quarter. 69.60% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings upgraded shares of Utah Medical Products from a "hold (c-)" rating to a "hold (c)" rating in a research report on Wednesday, August 12th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Utah Medical Products has a consensus rating of "Hold".
Check Out Our Latest Stock Report on Utah Medical Products
Utah Medical Products Trading Down 1.1%
Utah Medical Products stock opened at $70.21 on Tuesday. Utah Medical Products, Inc. has a 12 month low of $53.66 and a 12 month high of $75.75. The business's 50 day simple moving average is $69.59 and its 200 day simple moving average is $66.62. The company has a market cap of $223.55 million, a price-to-earnings ratio of 21.41 and a beta of 0.35.
Utah Medical Products (NASDAQ:UTMD - Get Free Report) last announced its quarterly earnings data on Thursday, July 23rd. The medical instruments supplier reported $0.84 earnings per share for the quarter. The business had revenue of $8.53 million during the quarter. Utah Medical Products had a return on equity of 8.74% and a net margin of 29.04%.
Utah Medical Products Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Monday, October 5th. Stockholders of record on Thursday, September 17th will be paid a dividend of $0.31 per share. The ex-dividend date is Thursday, September 17th. This represents a $1.24 annualized dividend and a dividend yield of 1.8%. Utah Medical Products's dividend payout ratio is presently 37.80%.
About Utah Medical Products
(
Free Report)
Utah Medical Products, Inc NASDAQ: UTMD, headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.
The company's core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).
Featured Stories
Want to see what other hedge funds are holding UTMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Utah Medical Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.
While Utah Medical Products currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
